The biology of cancer stem cells - PubMed (original) (raw)
Review
The biology of cancer stem cells
Neethan A Lobo et al. Annu Rev Cell Dev Biol. 2007.
Abstract
Cancers originally develop from normal cells that gain the ability to proliferate aberrantly and eventually turn malignant. These cancerous cells then grow clonally into tumors and eventually have the potential to metastasize. A central question in cancer biology is, which cells can be transformed to form tumors? Recent studies elucidated the presence of cancer stem cells that have the exclusive ability to regenerate tumors. These cancer stem cells share many characteristics with normal stem cells, including self-renewal and differentiation. With the growing evidence that cancer stem cells exist in a wide array of tumors, it is becoming increasingly important to understand the molecular mechanisms that regulate self-renewal and differentiation because corruption of genes involved in these pathways likely participates in tumor growth. This new paradigm of oncogenesis has been validated in a growing list of tumors. Studies of normal and cancer stem cells from the same tissue have shed light on the ontogeny of tumors. That signaling pathways such as Bmi1 and Wnt have similar effects in normal and cancer stem cell self-renewal suggests that common molecular pathways regulate both populations. Understanding the biology of cancer stem cells will contribute to the identification of molecular targets important for future therapies.
Similar articles
- Cancer stem cells: an insight and future perspective.
Kaur S, Singh G, Kaur K. Kaur S, et al. J Cancer Res Ther. 2014 Oct-Dec;10(4):846-52. doi: 10.4103/0973-1482.139264. J Cancer Res Ther. 2014. PMID: 25579517 Review. - Self-renewal and solid tumor stem cells.
Al-Hajj M, Clarke MF. Al-Hajj M, et al. Oncogene. 2004 Sep 20;23(43):7274-82. doi: 10.1038/sj.onc.1207947. Oncogene. 2004. PMID: 15378087 Review. - FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B, Wang X, Hallett RM, Venugopal C, Mack SC, McFarlane N, Nolte SM, Scheinemann K, Gunnarsson T, Hassell JA, Taylor MD, Lee C, Triscott J, Foster CM, Dunham C, Hawkins C, Dunn SE, Singh SK. Manoranjan B, et al. Stem Cells. 2013 Jul;31(7):1266-77. doi: 10.1002/stem.1401. Stem Cells. 2013. PMID: 23592496 - New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells.
Zhao RC, Zhu YS, Shi Y. Zhao RC, et al. Pharmacol Ther. 2008 Jul;119(1):74-82. doi: 10.1016/j.pharmthera.2008.04.008. Epub 2008 May 20. Pharmacol Ther. 2008. PMID: 18562010 Review. - Regulation of Stem Cell Self-Renewal and Oncogenesis by RNA-Binding Proteins.
Hattori A, Buac K, Ito T. Hattori A, et al. Adv Exp Med Biol. 2016;907:153-88. doi: 10.1007/978-3-319-29073-7_7. Adv Exp Med Biol. 2016. PMID: 27256386
Cited by
- Cells of origin and tumor-initiating cells for nonmelanoma skin cancers.
Thieu K, Ruiz ME, Owens DM. Thieu K, et al. Cancer Lett. 2013 Sep 10;338(1):82-8. doi: 10.1016/j.canlet.2012.05.008. Epub 2012 May 11. Cancer Lett. 2013. PMID: 22579650 Free PMC article. Review. - Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.
Chen SF, Lin YS, Jao SW, Chang YC, Liu CL, Lin YJ, Nieh S. Chen SF, et al. PLoS One. 2013 May 1;8(5):e54659. doi: 10.1371/journal.pone.0054659. Print 2013. PLoS One. 2013. PMID: 23658677 Free PMC article. - The differentiation of pancreatic tumor-initiating cells by vitronectin can be blocked by cilengitide.
Cabarcas SM, Sun L, Mathews L, Thomas S, Zhang X, Farrar WL. Cabarcas SM, et al. Pancreas. 2013 Jul;42(5):861-70. doi: 10.1097/MPA.0b013e318279d568. Pancreas. 2013. PMID: 23462327 Free PMC article. - Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias.
Ziegler P, Chahoud T, Wilhelm T, Pällman N, Braig M, Wiehle V, Ziegler S, Schröder M, Meier C, Kolodzik A, Rarey M, Panse J, Hauber J, Balabanov S, Brümmendorf TH. Ziegler P, et al. Invest New Drugs. 2012 Dec;30(6):2274-83. doi: 10.1007/s10637-012-9810-1. Epub 2012 Mar 14. Invest New Drugs. 2012. PMID: 22415796 - Regulation of cell growth by Notch signaling and its differential requirement in normal vs. tumor-forming stem cells in Drosophila.
Song Y, Lu B. Song Y, et al. Genes Dev. 2011 Dec 15;25(24):2644-58. doi: 10.1101/gad.171959.111. Genes Dev. 2011. PMID: 22190460 Free PMC article.
Publication types
MeSH terms
Grants and funding
- CA 126524/CA/NCI NIH HHS/United States
- DK 53074/DK/NIDDK NIH HHS/United States
- CA 100225/CA/NCI NIH HHS/United States
- CA 104987/CA/NCI NIH HHS/United States
- T32 GM007315/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources